Cochrane Abstracts
Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review
Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Addition to Inhaled Corticosteroids of Long-acting Beta 2 -agonists Versus Anti-leukotrienes for Chronic Asthma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/Addition_to_inhaled_corticosteroids_of_long_acting_beta_2__agonists_versus_anti_leukotrienes_for_chronic_asthma:_Cochrane_systematic_review. Accessed 26 June 2022.
Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/Addition_to_inhaled_corticosteroids_of_long_acting_beta_2__agonists_versus_anti_leukotrienes_for_chronic_asthma:_Cochrane_systematic_review. Accessed June 26, 2022.
Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/Addition_to_inhaled_corticosteroids_of_long_acting_beta_2__agonists_versus_anti_leukotrienes_for_chronic_asthma:_Cochrane_systematic_review
Addition to Inhaled Corticosteroids of Long-acting Beta 2 -agonists Versus Anti-leukotrienes for Chronic Asthma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 June 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/Addition_to_inhaled_corticosteroids_of_long_acting_beta_2__agonists_versus_anti_leukotrienes_for_chronic_asthma:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Addition to inhaled corticosteroids of long-acting beta 2 -agonists versus anti-leukotrienes for chronic asthma: Cochrane systematic review
ID - 432810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432810/all/Addition_to_inhaled_corticosteroids_of_long_acting_beta_2__agonists_versus_anti_leukotrienes_for_chronic_asthma:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
